Nutrition 21, Inc. reported today that a peer reviewed analysis on chromium picolinate was published in the current edition of Diabetes Technology & Therapeutics. The analysis confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes.(1)

Additional research presented at the 19th World Diabetes Congress Meeting supports the efficacy and safety of chromium picolinate in diabetes management